Primary Site >> Esophagus Cancer
Gene >> STAT3
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Epidermal growth factor inhibits the growth of TE8 esophageal cancer cells through the activation of STAT1. PMID: 12162406 |
Ref: Interleukin-6 acts as an antiapoptotic factor in human esophageal carcinoma cells through the activation of both STAT3 and mitogen-activated protein kinase pathways. PMID: 14586407 |
Ref: [Expression and clinical significance of COX-2, p-Stat3, and p-Stat5 in esophageal carcinoma]. PMID: 17672932 |
Ref: beta-Catenin/TCF pathway upregulates STAT3 expression in human esophageal squamous cell carcinoma. PMID: 18602747 |
Ref: Gensenoside Rg3 inhibits hypoxia-induced VEGF expression in human cancer cells. PMID: 21220916 |
Ref: Reciprocal activation between PLK1 and Stat3 contributes to survival and proliferation of esophageal cancer cells. PMID: 22108192 Ref: The role of DNA methyltransferase 3b in esophageal squamous cell carcinoma. PMID: 22213175 Ref: Phosphorylation of signal transducer and activator of transcription 3 (STAT3) correlates with Her-2 status, carbonic anhydrase 9 expression and prognosis in esophageal cancer. PMID: 22484976 Ref: PSK induces apoptosis through the inhibition of activated STAT3 in human esophageal carcinoma cells. PMID: 22552778 Ref: Let-7 expression is a significant determinant of response to chemotherapy through the regulation of IL-6/STAT3 pathway in esophageal squamous cell carcinoma. PMID: 22847808 |
Ref: IL-6 expression predicts treatment response and outcome in squamous cell carcinoma of the esophagus. PMID: 23561329 Ref: Inhibiting interleukin-19 activity ameliorates esophageal squamous cell carcinoma progression. PMID: 24130695 |
Ref: Apurinic/apyrimidinic endonuclease-1 is associated with angiogenesis and VEGF production via upregulation of COX-2 expression in esophageal cancer tissues. PMID: 24284961 Ref: Downregulation of LKB1 suppresses Stat3 activity to promote the proliferation of esophageal carcinoma cells. PMID: 24676538 Ref: RNA-seq reveals determinants of sensitivity to chemotherapy drugs in esophageal carcinoma cells. PMID: 24817948 Ref: STAT3 inhibitor NSC74859 radiosensitizes esophageal cancer via the downregulation of HIF-1alpha. PMID: 24981247 Ref: ErbB targeting inhibitors repress cell migration of esophageal squamous cell carcinoma and adenocarcinoma cells by distinct signaling pathways. PMID: 25091467 Ref: Activating transcription factor 4 mediates a multidrug resistance phenotype of esophageal squamous cell carcinoma cells through transactivation of STAT3 expression. PMID: 25130172 Ref: IL-6-stimulated CD11b+ CD14+ HLA-DR- myeloid-derived suppressor cells, are associated with progression and poor prognosis in squamous cell carcinoma of the esophagus. PMID: 25238263 |
Ref: Nimesulide inhibits the growth of human esophageal carcinoma cells by inactivating the JAK2/STAT3 pathway. PMID: 25724470 Ref: 1alpha,25-Dihydroxyvitamin D3 Inhibits Esophageal Squamous Cell Carcinoma Progression by Reducing IL6 Signaling. PMID: 25824337 Ref: STAT3 is involved in miR-124-mediated suppressive effects on esophageal cancer cells. PMID: 25928665 Ref: Prognostic Role of Phospho-STAT3 in Patients with Cancers of the Digestive System: A Systematic Review and Meta-Analysis. PMID: 26024373 Ref: Molecular characterization of antitumor effects of the rhizome extract from Curcuma zedoaria on human esophageal carcinoma cells. PMID: 26498695 Ref: Expression of activated signal transducer and activator of transcription-3 as a predictive and prognostic marker in advanced esophageal squamous cell carcinoma. PMID: 26553224 |
Ref: Reciprocal activation between STAT3 and miR-181b regulates the proliferation of esophageal cancer stem-like cells via the CYLD pathway. PMID: 27189061 Ref: The Synthetic beta-Nitrostyrene Derivative CYT-Rx20 Inhibits Esophageal Tumor Growth and Metastasis via PI3K/AKT and STAT3 Pathways. PMID: 27875549 Ref: Antitumor activity of 7RH, a discoidin domain receptor 1 inhibitor, alone or in combination with dasatinib exhibits antitumor effects in nasopharyngeal carcinoma cells. PMID: 27900042 |
Ref: Nardilysin promotes hepatocellular carcinoma through activation of signal transducer and activator of transcription 3. PMID: 28207963 Ref: Icariin exerts inhibitory effects on the growth and metastasis of KYSE70 human esophageal carcinoma cells via PI3K/AKT and STAT3 pathways. PMID: 28667862 Ref: Constitutive activated STAT3 is an essential regulator and therapeutic target in esophageal squamous cell carcinoma. PMID: 29179470 |
Ref: Thymoquinone Augments Cisplatin-Induced Apoptosis on Esophageal Carcinoma Through Mitigating the Activation of JAK2/STAT3 Pathway. PMID: 29197940 Ref: Plumbagin inhibits the proliferation and survival of esophageal cancer cells by blocking STAT3-PLK1-AKT signaling. PMID: 29339720 Ref: The effect of curcumin on cell adhesion of human esophageal cancer cell. PMID: 29424917 Ref: Down-regulation of STAT3 induces the apoptosis and G1 cell cycle arrest in esophageal carcinoma ECA109 cells. PMID: 29636641 Ref: IL-6 Mediates Cross-Talk between Tumor Cells and Activated Fibroblasts in the Tumor Microenvironment. PMID: 29976575 Ref: TRIM44 promotes human esophageal cancer progression via the AKT/mTOR pathway. PMID: 30098109 Ref: The Curcumin Analogs 2-Pyridyl Cyclohexanone Induce Apoptosis via Inhibition of the JAK2-STAT3 Pathway in Human Esophageal Squamous Cell Carcinoma Cells. PMID: 30186159 Ref: Clinical significance of interleukin-6 in diagnosis of lung, oral, esophageal, and gall bladder carcinomas. PMID: 30249899 |